Table 6 Results of Subgroup Analysis on Impact of FASDs on Mortality, stratified by Mortality Cause.
FASD (n = 3,103) | General Population (n = 15,515) | None | Mortality | |||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | ||||||||
n | % | n | % | Lower | Upper | |||||
Mortality Causes | ||||||||||
All-Causes | 387 | 12.5 | 736 | 4.7 | 1.00 | 1.33 | 1.07 | – | 1.67 | 0.0118 |
Neoplasm | 94 | 3.0 | 234 | 1.5 | 1.00 | 0.88 | 0.59 | – | 1.32 | < .0001 |
Circulatory | 89 | 2.9 | 151 | 1.0 | 1.00 | 2.07 | 1.34 | – | 3.18 | < .0001 |
Digestive | 35 | 1.1 | 30 | 0.2 | 1.00 | 3.63 | 1.66 | – | 7.93 | 0.0012 |
Respiratory | 31 | 1.0 | 36 | 0.2 | 1.00 | 2.51 | 1.15 | – | 5.48 | 0.0215 |
Endocrine | 29 | 0.9 | 33 | 0.2 | 1.00 | 3.04 | 1.33 | – | 6.96 | 0.0085 |
Nervous | 26 | 0.8 | 19 | 0.1 | 1.00 | 4.15 | 1.54 | – | 11.17 | 0.0049 |
External* | 25 | 0.8 | 94 | 0.6 | 1.00 | 1.26 | 0.65 | – | 2.44 | 0.4957 |
Abnormal | 20 | 0.6 | 73 | 0.5 | 1.00 | 0.77 | 0.32 | – | 1.85 | 0.5590 |
Infectious | 17 | 0.5 | 22 | 0.1 | 1.00 | 2.22 | 0.72 | – | 6.81 | 0.1647 |
Other** | 21 | 0.7 | 44 | 0.3 | 1.00 | 0.77 | 0.72 | – | 0.82 | < .0001 |